Today, the New Zealand Government continues to choose CSL Biotherapies as New Zealand’s national plasma fractionator. Regulated by Medsafe, a regulator held in high regard worldwide, CSL Biotherapies and the New Zealand Blood Service ensure that the blood and plasma donations made voluntarily by people living in New Zealand continue to deliver the benefits that self-reliance provides – a sustainable, reliable and high quality source of plasma-derived therapies, developed to treat serious medical conditions including immunodeficiency disorders, a range of haematological and neurological disorders, haemophilia, haemolytic disease of the newborn and trauma. A range of products is also available to provide protection against infectious diseases including hepatitis B, tetanus and chickenpox.

Blood and plasma donated by New Zealand’s donors is fractionated into twelve plasma-derived therapies at CSL Biotherapies' unique, purpose-built, chromatographic plasma fractionation facility, located at Broadmeadows in Victoria, Australia. For more information about these products, please refer to the table below.

A-Z of New Zealand Products

A B H I M N P R T Z

Product Name	Subcategory	Description
A
ALBUMEX^® 4	Critical Care	Used when the blood volume is low, during heart-lung bypass surgery, and in plasma exchange.
ALBUMEX^® 20	Critical Care	Used when quantity of albumin in blood is low, for resuscitation in shock, in extensive burns, respiratory distress syndrome, blood purification and plasma exchange.
B
BIOSTATE^®	Coagulation Disorders	Used for patients with haemophilia A, in which there are reduced levels of factor VIII.
H
Hepatitis B Immunoglobulin-VF	Immune Therapy	Used to help prevent hepatitis B infection in a person who comes into contact with suspected infected material.
I
INTRAGAM^® P	Immune Therapy	Used to replace antibodies to help prevent infections and also used in the treatment of some autoimmune disorders.
M
MonoFIX^®-VF	Coagulation Disorders	Used in patients with haemophilia B, in which there are reduced levels of Factor IX.
N
Normal Immunoglobulin-VF	Immune Therapy	Used for the replacement of antibodies to help prevent infections.
P
PROTHROMBINEX™-VF	Coagulation Disorders	Used for the prevention and treatment of bleeding in patients with reduced levels of factor IX, II or X.
R
Rh(D) Immunoglobulin-VF	Immune Therapy	Used to prevent Haemolytic Disease of the Newborn.
T
Tetanus Immunoglobulin-VF IM	Immune Therapy	Used to help prevent tetanus in a person who has not recently been immunised against tetanus.
THROMBOTROL^®-VF	Critical Care	Used for the treatment patients with conditions relating to an inherited deficiency of antithrombin III.
Z
Zoster Immunoglobulin-VF	Immune Therapy	Used to help prevent chickenpox and shingles.

CSL | Privacy | Terms of Use | Webmaster